ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

Endoscopic Surgery Provides Equal Or Better Results

September 30, 2005